<PAGE> 1
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
--------------
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
--------------------------------------
Date of Report (Date of earliest event reported): July 28, 2000
BIOSPHERE MEDICAL, INC.
--------------------------------------------------------------
(Exact name of registrant as specified in its Charter)
Delaware 0-23678 04-3216867
------------------------- ------------ -----------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
1050 Hingham St. Rockland, Massachusetts 02370
----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (781) 681-7900
111 Locke Drive, Marlborough, MA 01752
----------------------------------------------------
(Former Name or Former Address if Changed Since Last Report)
================================================================================
Page 1 of 6
<PAGE> 2
ITEM 5. OTHER EVENTS. On July 31, 2000, BioSphere Medical, Inc. (the
"Company") issued a press release (which is attached hereto as Exhibit
99.1) to announce that it had completed a private placement of shares of
its Common Stock, $.01 par value per share (the "Shares"), to selected
institutional and accredited investors (the "Purchasers"), for aggregate
proceeds of approximately $13.0 million or $11.00 per share. The Company
expects to promptly file a resale registration statement on Form S-3 on
behalf of the Purchasers for the purposes of registering the Shares for
resale from time to time by the Purchasers.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(C) Exhibits.
99.1 The Registrant's Press Release dated July 31, 2000.
Page 2 of 6
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereto duly authorized.
BioSphere Medical, Inc.
(Registrant)
Date: August 4, 2000 /s/ Robert M. Palladino
--------------------------------
Vice President and
Chief Financial Officer
Page 3 of 6
<PAGE> 4
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number(s)
99.1 The Registrant's Press Release
dated July 31, 2000 5
Page 4 of 6
